样式: 排序: IF: - GO 导出 标记为已读
-
Small Intestinal Bacterial Overgrowth Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-08-22 Eden Sharabi, Ali Rezaie
Purpose of review Small intestinal bacterial overgrowth (SIBO) is a chronic gastrointestinal disorder wherein excessive and abnormal growth of bacteria in the small bowel generally causes abdominal pain, bloating, and change in bowel habits. Our understanding of the underlying pathology and microbiome changes in SIBO has advanced greatly in the last 20 years in parallel with advances in treatment methods
-
Nontuberculous Mycobacteria Pulmonary Infection in Children with Cystic Fibrosis Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-08-02 Sabiha R. Hussain, Amira M. Said, Jeffrey R. Starke
Purpose of Review As children and adolescents with cystic fibrosis (CF) have lived longer, they have become more susceptible to pulmonary infection with nontuberculous mycobacteria (NTM). Most NTM infections are caused by the Mycobacterium avium complex (MAC) or Mycobacterium abscessus. We review what is currently known and recommended for treatment of these infections. Recent Findings Treatment of
-
Gastrointestinal Manifestation of MPox Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-07-11 Timothy Trestrail, Karishma Kodia, Vanessa W. Hui
-
Contemporary Management of Pediatric Invasive Fungal Rhinosinusitis Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-06-08 Sheng Zhou, Alison Yu, Ethan Frank, Bastien A. Valencia-Sanchez, Sonja Chen, Sean P. Polster, Vijay A. Patel
-
Climate Change and Meningoencephalitis in the Americas: A Brewing Storm Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-05-29 Elyssa Dionne, Francisco Machiavello Roman, Shelli Farhadian
Purpose of Review Climate change has significantly impacted the ecological interactions between pathogens, vectors and human populations. Regional variations in temperature and precipitation patterns have shifted the geographic spread and seasonality of infectious diseases. Cases of meningoencephalitis, in particular those caused by vector-borne infections, are likewise expected to display changes
-
Norovirus Infection in Transplant Recipients Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-05-18 Matthew Ringer, Maricar Malinis
Purpose of Review Norovirus is a leading cause of diarrhea in transplant recipients. Norovirus can cause a severe acute syndrome in this patient population. Transplant recipients can also develop a chronic diarrheal syndrome with associated frailty, prolonged viral shedding, hospitalizations, and rejection, with associated mortality. Despite the significant burden of disease and improved diagnostics
-
Role of Povidone-Iodine in Reducing Surgical Site Infection Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-04-11 A. Haleem, C. L. Abad
Purpose of Review Surgical site infections (SSIs) are associated with significant morbidity and mortality. Given the role of endogenous carriage of Staphylococcus aureus, current patient decolonization strategies revolve around the application of topical antiseptic agents prior to and at the time of surgery. Recent Findings Intranasal single-application povidone-iodine (PVP-I) on the day of surgery
-
Care Bundles in Surgical Site Infection Prevention: A Narrative Review Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-03-01 Patrick R. Ching
Purpose of Review Surgical site infections are healthcare-associated infections that cause significant morbidity and mortality. Best practices in prevention of these infections are combined in care bundles for consistent implementation. Recent Findings Care bundles have been used in nearly all surgical specialties. While the composition and size of bundles vary, the effect of a bundle depends on the
-
Exploring the Potential of Farnesol as a Novel Antifungal Drug and Related Challenges Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-02-26 Dongming Zheng, Linlan Yang, Yuxin Bai, Jiangyan Yong, Yan Li
Purpose of Review Farnesol (FOH) is a quorum-sensing molecule with potential as an antifungal drug. Given the growing concern about fungal drug resistance, exploring new solutions is crucial. Therefore, summarizing the antifungal activity of FOH is expected to be the basis for further FOH research and application. Herein, we reviewed the in vitro and in vivo antifungal efficacy of FOH alone and in
-
Tebipenem and Sulopenem: Dynamic Duo or Double Trouble? Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-02-10 Blake R. Mangum, Jason M. Pogue, Katie E. Barber
Purpose of Review Antimicrobial resistance is a growing threat to public health, leading to millions of antibiotic-resistant infections and thousands of deaths annually in the USA. One concerning issue is the rise of extended-spectrum beta-lactamase (ESBL)–producing Enterobacterales. Current treatments often involve intravenous carbapenems, leading to prolonged hospital stays and financial burdens
-
A Review of Therapeutic Drug Monitoring of Beta-Lactams Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-02-03 Austin Paytes, Jeremy Frens, Ryan McCormick
Purpose of Review Beta-lactam antibiotics are among the most commonly prescribed drug classes in the hospital setting. The pharmacokinetic/pharmacodynamic index correlated with bactericidal activity of beta-lactam antibiotics is the amount of time drug concentrations exceeds the minimum inhibitory concentration over the course of a dosing interval. Standard dosing is based on preclinical trials conducted
-
Out with the Old, In with the New: A Review of the Treatment of Intrapartum Infections Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-01-30 Pamela Bailey, Lance Schacht, Grace Pazienza, Patricia Seal, Amy Crockett, Julie Ann Justo
Purpose of Review In 2019, a global meta-analysis demonstrated incidence of 3.9% for chorioamnionitis, 1.6% for endometritis, 1.2% for wound infection, 0.05% for sepsis, and 1.1% for maternal peripartum infection (Woodd et al. in PLOS Med 16(12):e1002984, 2019). Antimicrobial regimens for these infections are based on older microbiology profiles and may not account for changes in antimicrobial susceptibility
-
Subtleties and differences of managing ICU patients across South Africa, Australia and UK Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-01-22 Robert Wise, Rebecca Whittaker, Tessa Garside
-
Septic Coagulopathy: Pathophysiology, Diagnosis, and Therapeutic Strategies Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-01-22 Toshiyuki Karumai, Yuki Kotani, Ryohei Yamamoto, Mayuko Tonai, Yoshiro Hayashi
-
Difficult to Treat Gram-Negative Bacteria—The Indian Scenario Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-01-20 Niraj Bannore, Farhad Kapadia, Ashit Hegde
-
Whole Genome Sequencing Applications in Hospital Epidemiology and Infection Prevention Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-01-19 Michelle Doll, Alexandra L. Bryson, Tara N. Palmore
Purpose of Review Whole genome sequencing is increasingly used in epidemiologic surveillance in healthcare centers, shedding new light on the transmission of healthcare-associated infections. As processing times for these technologies shorten, the ability to use sequencing data for targeted infection prevention is seemingly attainable and of great interest to infection prevention practitioners in an
-
The Verdict on Vancomycin and Piperacillin/Tazobactam-Associated Nephrotoxicity: Acquittal by Biomarkers or Guilty as Charged? Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-01-19 Sara Lee, Emily Heil
Purpose of Review Current literature largely suggests that the combination of vancomycin and piperacillin/tazobactam (VPT) is associated with a significantly higher risk of acute kidney injury (AKI) compared to vancomycin alone or in combination with other antipseudomonal beta-lactams. However, the true mechanisms behind this potential nephrotoxic effect remain unclear. Recent Findings The majority
-
Long Story Short: Establishing Breakpoints for Antimicrobials and 2023 Updates Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-01-18 Morgan L. Bixby, Dina Zheng, Elizabeth B. Hirsch
-
Recent Advancements in the Therapeutic Development for Marburg Virus: Updates on Clinical Trials Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-01-15 Garima Sharma, Ashish Ranjan Sharma, Jin-Chul Kim
-
An Update on Suppurative Tenosynovitis Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-01-03 Wissam El Atrouni, Mitchell C. Birt, Rachel Weihe
-
HBV Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors (BTKIs): a Systematic Review and Meta-Analysis Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2024-01-03 Ahmed Azzam, Heba Khaled, Basem Osama Ashry, Sarah Mohamed Hussein, Manar Osama, Ameer Ahmed, Omar Yousef, Anees Hjazeen, Ahmed A. Allam, Gellan Alaa Mohamed Kamel
-
Defining International Critical Care Pharmacist Contributions to Sepsis and Exploring Variability Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-12-20 Robert Oakley, Sarraa Al-Mahdi, Sonja Guntschnig, Ha Trinh, Marco Custodio, Sarah Korshid, Andries Gous, Dagan O. Lonsdale
-
Antibiotic Use at Hospital Discharge and Outpatient Antimicrobial Stewardship Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-11-20 Mandee Noval, Colleen Burgoyne, Jacinta Chin, Kathryn Dzintars, Aileen Jimenez, Angela Perhac, Jessa Brenon
Purpose of Review Inappropriate and unnecessary antibiotic prescriptions are common in the outpatient setting and as patients transition from inpatient to outpatient care. This review is designed to discuss effective strategies aimed to improve appropriate antibiotic use during transitions of care and in the outpatient setting for high-priority syndrome areas including acute respiratory infections
-
Complex Outpatient Antimicrobial Therapy: Alternative Management Strategies and Outcomes Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-11-04 Tucker John Guy Smith, Peter Daniels, Barry Rittmann
Purpose of Review Outpatient parenteral antibiotic therapy (OPAT) faces challenges requiring alternative solutions to long-term OPAT and skilled nursing facility (SNF) placement, particularly in persons who inject drugs (PWID). Recent Findings SNF placement for antibiotic therapy is not ideal due to high rates of iatrogenic infections, social and financial burden, and poor outcomes for PWID. Hospital-at-home
-
Rebuilding for Tomorrow’s Outbreak: The State of Special Pathogen Preparedness in the USA in the Wake of COVID-19 Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-11-01 Jade B. Flinn, Amy D. Britton, Jennifer Garland, Jennifer Cuzzolina, Paul D. Biddinger, Vikramjit Mukherjee, Jonathan D. Grein
-
The Opportunities and Challenges for Artificial Intelligence to Improve Sepsis Outcomes in the Paediatric Intensive Care Unit Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-10-31 Abdullah Tarik Aslan, Budi Permana, Patrick N. A. Harris, Kuban D. Naidoo, Michael A. Pienaar, Adam D. Irwin
Purpose of Review To describe existing applications of artificial intelligence (AI) in sepsis management and the opportunities and challenges associated with its implementation in the paediatric intensive care unit. Recent Findings Over the last decade, significant advances have occurred in the use of AI techniques, particularly in relation to medical image analysis. Increasingly, these techniques
-
One Small Step (Down) for Antibiotics, One Giant Leap for Outpatient Therapy: The Role of Oral Antibiotics in Serious Bacterial Infections Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-10-31 Jessica K. Ortwine, Wenjing Wei, Norman S. Mang, Brenton C. Hall, Helen Ding
Purpose of Review Stepping down to oral antibiotic therapy after a period of IV lead-in would eliminate most of the untoward effects of long-term intravenous therapy, including lengthy hospital admissions, copays for ambulatory infusions, catheter-related adverse events, and missed work/school. Recent Findings Two randomized, controlled trials, POET and OVIVA, contribute significant support for oral
-
Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-10-27 Caitlin Sande, Zoë J. Boston, Lindsay R. Kalan, Meghan B. Brennan
-
Should We Tap That? Aspirates and Antibiotics: An Update on Septic Bursitis Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-10-27 Rachel Weihe, Mitchell C. Birt, Wissam El Atrouni
Purpose of Review Septic bursitis is a relatively common condition that causes substantial morbidity, but there is no universally accepted approach to management. We aim to evaluate recent literature with an eye toward recommended changes in the practice of bursal aspiration, surgical debridement, and antibiotic treatment. Recent Findings Authors of recent studies suggest that most patients with uncomplicated
-
What is New in Augmented Renal Clearance in Septic Patients? Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-10-26 Laura Baptista, Inês Moura, Catarina Mendes Silva, João Pedro Baptista
-
Infection Prevention in Remote or Resource-Limited Settings: Deploying Technology While Preserving the Human Touch Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-10-24 Rachel Pryor, Yashasvisai Veeramasu, Gonzalo Bearman
Purpose of Review Infection prevention (IP) programs face limited funding despite the COVID-19 pandemic and the continued threat of other novel pathogens. Healthcare epidemiologists and infection preventionists must continue to rely on technologies to support their work. This is especially true in remote or resource-limited settings where IP teams may not be physically present. Recent Findings Technologies
-
Challenges Facing PICUs in Low- and Middle-Income Countries in the Treatment of Emerging Multidrug-Resistant Organisms: a Review and Perspective from a South African PICU Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-10-14 Robin T. Saggers, Lesego M. Mothibi, Adam D. Irwin, Kuban D. Naidoo
-
Exploiting Electronic Data to Advance Knowledge and Management of Severe Infections Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-10-11 Kevin B. Laupland, Alexis Tabah, Kyle C. White, Mahesh Ramanan
Purpose of Review To identify opportunities and recent advances in the use of multicentric digital data sources and networks to investigate the epidemiology and management of patients with infections admitted to intensive care units (ICUs). Recent Findings Electronic surveillance systems for a range of serious infections have been reported from large cohorts with evident improvements in efficiency
-
Monkeypox 2022 vs. COVID-19: a Review on a National Health Emergency with Emphasis on Cutaneous Manifestations Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-09-18 Mohammad Rezaei Zadeh Rukerd, Pouria Pourzand, Nasir Arefinia, Davood Bashash, Amin Sayyadi, Mohsen Nakhaie, Simin Shamsi Meymandi
-
Mpox in 2023: Current Epidemiology and Management Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-09-02 Sapha Barkati, Luke B. Harrison, Marina B. Klein, Francesca F. Norman
-
Ebola and Marburg Virus Infections in Resource-Rich Countries: Implications for Future Outbreaks Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-08-30 Eyal Meltzer, Eli Schwartz
-
New Vaccines on the Immediate Horizon for Travelers: Chikungunya and Dengue Vaccines Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-08-23 Sonia Menon, Annelies Wilder-Smith
Purpose of Review Both chikungunya and dengue virus infections are frequent in international travelers to endemic areas. Recent Findings More than 11 chikungunya vaccines are in development, with one having completed phase 3 trials using a single dose, based on immune correlates as endpoint. Two live attenuated dengue vaccines are now licensed for use in travelers. Dengvaxia can only be used following
-
Prevalence and Resistance Patterns of Streptococcus pneumoniae Recovered from Children in Western Asia Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-07-03 Yasser M. Matran, Ahmed M. Al-Haddad, Divakar Sharma, Nitin Pal Kalia, Sarika Sharma, Manoj Kumar, Sandeep Sharma
-
Airport COVID-19 Testing of Travelers: An Island Destination Perspective Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-07-03 Amy T. Hou, Genevieve C. Pang, Kristin M. Mills, Krizhna L. Bayudan, Dayna M. Moore, Luz P. Medina, Lorrin W. Pang
Purpose of Review To highlight recent literature on airport COVID-19 testing studies among travelers at international borders and to identify factors that may contribute to bias. Recent Findings Literature search shows vastly different study designs and goals for airport COVID-19 screening programs, with positivity rates ranging from 0.1 to 100%. Goals included detecting the maximum cases with enforced
-
Human Papilloma Virus Related Cancers in People Living with HIV Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-06-30 Nicola Squillace, Viola Cogliandro, Alice Ranzani, Nicholas Brian Bana, Paolo Bonfanti
Purpose of Review The burden of HPV co-infection in people living with HIV is high leading to increase incidence of HPV-related malignancies. Antiretroviral therapy and HPV vaccination appears to have made a significant impact on the prevention and treatment of HPV-related cancers. Recent Findings Cervical and anal cancer data on survival and risk factors in people living with HIV showed a better prognosis
-
Japanese Encephalitis: Emergence in Australia Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-06-26 Sarah L. McGuinness, Stephen Muhi, Philip N. Britton, Karin Leder
-
Updates on Malaria Epidemiology and Prevention Strategies Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-06-08 Marta González-Sanz, Pedro Berzosa, Francesca F. Norman
-
Healthcare Personnel Hand Hygiene Compliance: Are We There Yet? Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-05-26 JoDee Armstrong-Novak, Hui Yu Juan, Kaila Cooper, Pamela Bailey
Purpose of Review Poor hand hygiene is well documented as a factor in healthcare-associated infections and excellent rates of hand hygiene remains elusive. Recent Findings There is increased use of universal or increased gloving to minimize hand contamination, but its use does not replace hand hygiene opportunities. There is significant interest in electronic hand hygiene monitoring systems, but they
-
Management of Integrase Inhibitor-Associated Weight Gain: A Practical Clinical Approach Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-05-08 Brian R. Wood
Purpose of Review The purpose of this review is to outline a practical clinical approach to monitoring and managing integrase strand transfer inhibitor (INSTI)-associated weight gain, which may occur for persons with HIV following initiation or switch of antiretroviral therapy (ART). Recent Findings Numerous studies have found that INSTIs, especially dolutegravir and bictegravir, are associated with
-
Antibiotic Prophylaxis for Tooth Extractions and Dental Implants, A Narrative Review Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-05-04 Tumader Khouja, Erinne Kennedy, Katie J. Suda
Purpose of the review The aim of this review was to summarize recent evidence regarding recommendations for antibiotic prophylaxis in healthy patients undergoing dental extractions or implant procedures to prevent post extraction surgical site infection or implant failure. Recent findings Most studies identified in this review show little to no benefit of antibiotic prophylaxis in preventing surgical
-
Clinical Appraisal of Cefiderocol in the Treatment of Non-fermenting Gram-Negative Bacilli Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-03-14 Caleb C. McLeod, Karen K. Tan, Razieh Kebriaei, Jacinda C. Abdul-Mutakabbir
-
Vulvovaginal Candidiasis in Postmenopausal Women Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-03-09 Mariel Becker, Ryan Sobel
Purpose of Review Vulvovaginal candidiasis (VVC) is one of the most common vaginal infections worldwide, but limited evidence-based data is available on postmenopausal women who develop this infection. As women transition through menopause, the effects of decreasing endogenous estrogen production on the vaginal environment have a significant impact on VVC infections in these women. In this review,
-
Lactobacillus iners and Genital Health: Molecular Clues to an Enigmatic Vaginal Species Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-03-07 Johanna B. Holm, Kayla A. Carter, Jacques Ravel, Rebecca M. Brotman
-
Climate Change and Travel: Harmonizing to Abate Impact Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-03-01 Aisha N. Khatib
Purpose of Review With climate change being the single biggest health threat facing humanity, this review aims to identify the climate-sensitive health risks to the traveler and to recognize the role that travel plays in contributing to the detrimental effects of climate change. With this understanding, adaptations for transformational action can be made. Recent Findings Travel and tourism, including
-
Role of Antifungal Susceptibility Tests in the Treatment of Vulvovaginal Candidiasis Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-02-22 J. D. Sobel
Purpose of Review The increased prevalence of antifungal drug resistance associated with common vaginal pathogen C. albicans as well as non-albicans Candida species is now widespread in association with refractory and breakthrough vulvovaginal candidiasis (VVC). Recent Findings Physicians currently empirically select antifungal agents without knowledge and access to antifungal susceptibility tests
-
When Should Oral Vancomycin Prophylaxis be Used to Prevent C. difficile Infection? Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-02-06 Andrew Darkow, Steven Johnson, Harrison Walker, David H. Priest
Purpose of Review It is unclear if oral vancomycin prophylaxis (OVP) should be used to reduce the risk of Clostridioides difficile infection (CDI) during systemic antibiotic exposure, and which patients benefit most from this approach. This review seeks to evaluate currently available literature on the utility of OVP, discuss clinical controversies, and suggest when OVP may be considered. Recent Findings
-
Does Bacterial Vaginosis Contribute to Urinary Tract Infection? Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2023-01-25 Victoria L. Handa, Rebecca M. Brotman, Jacques Ravel, Susan Tuddenham
Purpose of Review Antibiotic-sparing therapies to treat and prevent urinary tract infections (UTIs) are needed. Interest surrounds the question of whether bacterial vaginosis (BV) enhances susceptibility to urinary tract infections (UTIs) in women, and, whether, by extension, the vaginal microbiota could serve as a therapeutic target for UTI prevention. In this review, we outline research on the relationship
-
Role of Obesity in Recurrent Vulvovaginal Symptoms and Disease Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2022-12-27 Anna Maya Powell, Isabella Sarria, Oluwatosin Goje
Purpose of Review To highlight recent literature that discusses the association of overweight and obesity with vaginal dysbiosis and symptomatic vulvovaginitis among non-pregnant women. Recent Findings Literature search on vaginitis showed varying results regarding associations between obesity, vaginal dysbiosis, yeast vulvovaginitis, and vulvar disorders. There was no convincing relationship between
-
Bacterial Vaginosis in Postmenopausal Women Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2022-12-15 Olivia T. Van Gerwen, Sarah E. Smith, Christina A. Muzny
Purpose of Review Bacterial vaginosis (BV) is the most common vaginal infection worldwide, but most research has been conducted in premenopausal women. After menopause, endogenous estrogen production decreases, often leading to the genitourinary syndrome of menopause (GSM), characterized by vulvovaginal dryness and irritation. The estrogen-deficient postmenopausal state results in an elevated vaginal
-
Chikungunya: An Emerging Public Health Concern Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2022-11-17 Omar Mourad, Leila Makhani, Lin H. Chen
-
Loop-Mediated Isothermal Amplification–Based Microfluidic Platforms for the Detection of Viral Infections Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2022-11-02 Yuanyuan Zeng, Chuan Wu, Yang He
-
No Crystal Ball? Using Risk Factors and Scoring Systems to Predict Extended-Spectrum Beta-Lactamase Producing Enterobacterales (ESBL-E) and Carbapenem-Resistant Enterobacterales (CRE) Infections Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2022-10-06 Cecilia Li, Kimberly C. Claeys, Julie A. Justo, Emily L. Heil
-
Les misérables: a Parallel Between Antimicrobial Resistance and COVID-19 in Underdeveloped and Developing Countries Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2022-10-04 Genesy Pérez Jorge, Isabella Carolina Rodrigues dos Santos Goes, Marco Tulio Pardini Gontijo
Purpose of Review The COVID-19 pandemic has been responsible for more than 6.3 million deaths worldwide. During the pandemic, the indiscriminate use of antibiotics has increased, contributing to the spread of multidrug-resistant bacteria. In this review, we aim to determine the spread and impact of antibiotic treatments in patients with COVID-19, focusing on underdeveloped and developing countries
-
Interventions for the Prevention and Treatment of Japanese Encephalitis Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2022-09-23 Rohan Chand Sahu, Teeja Suthar, Anchal Pathak, Keerti Jain
-
Nosocomial Extracardiac Infections After Cardiac Surgery Curr. Infect. Dis. Rep. (IF 3.1) Pub Date : 2022-09-24 Enrico Maria Zardi, Massimo Chello, Domenico Maria Zardi, Raffaele Barbato, Omar Giacinto, Ciro Mastoianni, Mario Lusini
Purpose of Review Nosocomial extracardiac infections after cardiac surgery are a major public health issue affecting 3–8.2% of patients within 30–60 days following the intervention. Recent Findings Here, we have considered the most important postoperative infective complications that, in order of frequency, are pneumonia, surgical site infection, urinary tract infection, and bloodstream infection.